These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
318 results:

  • 1. Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from apc
    Arteaga-Blanco LA; Evans AE; Dixon DA
    Cells; 2024 Jul; 13(14):. PubMed ID: 39056778
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genomic Alterations and Clinical Characterization in Chinese Patients with Metastatic colorectal cancer.
    Zhang XH; Zhou JQ; Wei Q; Li J; Xu T; Bai CM; Zhou JF; Wang XC
    Discov Med; 2024 Jul; 36(186):1477-1485. PubMed ID: 39054718
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Long noncoding RNA LINC01550 inhibits colorectal cancer malignancy by suppressing the Wnt/β-catenin signaling pathway.
    Wu W; Li A; He H; Ye S; Zhou Z; Quan JH; Tan W
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23774. PubMed ID: 39041324
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Targeted panel sequencing of pharmacogenes and oncodrivers in colorectal cancer patients reveals genes with prognostic significance.
    Heczko L; Liška V; Vyčítal O; Fiala O; Šůsová S; Hlaváč V; Souček P
    Hum Genomics; 2024 Jul; 18(1):83. PubMed ID: 39030589
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Exploring heterogeneity: a dive into preclinical models of cancer cachexia.
    Morena F; Cabrera AR; Greene NP
    Am J Physiol Cell Physiol; 2024 Aug; 327(2):C310-C328. PubMed ID: 38853648
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Unlocking the potential of flavonoids: Natural solutions in the fight against colon cancer.
    Hasibuan PAZ; Simanjuntak Y; Hey-Hawkins E; Lubis MF; Rohani AS; Park MN; Kim B; Syahputra RA
    Biomed Pharmacother; 2024 Jul; 176():116827. PubMed ID: 38850646
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues.
    Busico A; Gasparini P; Rausa E; Cattaneo L; Bozzi F; Silvestri M; Capone I; Conca E; Tamborini E; Perrone F; Vitellaro M; Ricci MT; Casanova M; Chiaravalli S; Bergamaschi L; Massimino M; Milione M; Sozzi G; Pruneri G; Ferrari A; Signoroni S
    Sci Rep; 2024 Jun; 14(1):13138. PubMed ID: 38849509
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Incidence of common gene mutations in early-onset colorectal cancer and the association with cancer survival: a meta-analysis].
    Zhang RQ; Li SH; Hu TJ; Xu LY; Zhu YS; Li X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):495-506. PubMed ID: 38778689
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Superficial fibromas with CTNNB1 mutation.
    Kuntze A; Meliß RR; Ermert L; Falkenberg KD; Puller AC; Trautmann M; Hartmann W; Wardelmann E
    Genes Chromosomes Cancer; 2024 May; 63(5):e23247. PubMed ID: 38757718
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. colorectal cancer subtyping and immune landscape analysis based on natural killer cell-related genes.
    Ding M; Gao J; Wang J; Li Z; Gong X; Cui Z; Li C; Xue H; Li D; Wang Y
    Arab J Gastroenterol; 2024 May; 25(2):150-159. PubMed ID: 38719664
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
    Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
    Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
    [No Abstract]    [Full Text] [Related]  

  • 12. Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer.
    Mouillet-Richard S; Gougelet A; Passet B; Brochard C; Le Corre D; Pitasi CL; Joubel C; Sroussi M; Gallois C; Lavergne J; Castille J; Vilotte M; Daniel-Carlier N; Pilati C; de Reyniès A; Djouadi F; Colnot S; André T; Taieb J; Vilotte JL; Romagnolo B; Laurent-Puig P
    J Transl Med; 2024 Apr; 22(1):337. PubMed ID: 38589873
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. High Oestrogen receptor alpha expression correlates with adverse prognosis and promotes metastasis in colorectal cancer.
    Topi G; Satapathy SR; Ghatak S; Hellman K; Ek F; Olsson R; Ehrnström R; Lydrup ML; Sjölander A
    Cell Commun Signal; 2024 Mar; 22(1):198. PubMed ID: 38549115
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. CASC19: An Oncogenic Long Non-coding RNA in Different cancers.
    Wu Y; Mou J; Zhou G; Yuan C
    Curr Pharm Des; 2024; 30(15):1157-1166. PubMed ID: 38544395
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Dynamic ctDNA-based analysis of drug-resistant gene alterations at RAS/BRAF wild-type metastatic colorectal cancer patients after cetuximab plus chemotherapy as the first-line treatment.
    Zhou YW; Zhao X; Ni L; Cao P; Leng WB; Zhu Q; Gou HF; Zhang J; Li XF; Qiu M
    Int Immunopharmacol; 2024 Apr; 131():111887. PubMed ID: 38503018
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Canonical DDR activation by EMT inducing agent 5-Fluorouracil is modulated by a cannabinoid based combinatorial approach via inducing autophagy and suppression of vimentin expression.
    Mir KB; Chakraborty S; Amin T; Kumar A; Rouf War A; Nalli Y; Kumar R; Dinesh Kumar L; Ali A; Goswami A
    Biochem Pharmacol; 2024 May; 223():116126. PubMed ID: 38490521
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Negative prognostic impact of Co-mutations in TGFβ and TP53 pathways in surgically resected rectal tumors following neoadjuvant chemoradiotherapy.
    Qian C; Yang W; Li M; Feng Y; Dai N; Luo H; Jian D; Li X; Yang Y; He Y; Wang D; Li C; Xiao H
    Eur J Surg Oncol; 2024 Apr; 50(4):108242. PubMed ID: 38460248
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer.
    Hammarström K; Nunes L; Mathot L; Mezheyeuski A; Lundin E; Korsavidou Hult N; Imam I; Osterlund E; Sjöblom T; Glimelius B
    Int J Cancer; 2024 Jul; 155(1):40-53. PubMed ID: 38376070
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Genetic specificity study using next-generation sequencing (NGS) of peritoneal metastatic colorectal cancer compared to primary colorectal cancer.
    Lee S; Shin W; Park DG; Namgung H
    Genes Genomics; 2024 Mar; 46(3):289-302. PubMed ID: 38316717
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Liu C; Cheng X; Han K; Hong L; Hao S; Sun X; Xu J; Li B; Jin D; Tian W; Jin Y; Wang Y; Fang W; Bao X; Zhao P; Chen D
    Cancer Lett; 2024 Mar; 585():216663. PubMed ID: 38246221
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.